AAAAAA
Results: 26-40/40
Authors:
Neal, B
MacMahon, S
Chapman, N
Cutler, J
Fagard, R
Neal, B
Whelton, P
Yusuf, S
Agodoa, L
Baigent, C
Black, H
Boissel, JP
Brenner, B
Brown, M
Bulpitt, C
Byington, R
Chalmers, J
Collins, R
Dahlof, B
Davis, B
Estacio, R
Fox, K
Hansson, L
Holman, R
Hunsicker, L
Kostis, J
Kuramoto, K
Kusek, J
Lees, R
Lewis, E
Lindholm, LH
Liu, L
Lubsen, J
Malacco, E
Mancia, G
Martin, I
Pepine, C
Pfeffer, M
Pitt, B
Poole-Wilson, P
Remuzzi, G
Rodgers, A
Ruggenenti, P
Schrier, R
Sever, P
Sleight, P
Staessen, J
Teo, K
Turner, R
Wing, L
Zanchetti, A
Algert, C
Woodward, M
Citation: B. Neal et al., Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials, LANCET, 356(9246), 2000, pp. 1955-1964
Authors:
Hansson, L
Hedner, T
Lund-Johansen, P
Kjeldsen, SE
Lindholm, LH
Syvertsen, JO
Lanke, J
de Faire, U
Dahlof, B
Karlberg, BE
Citation: L. Hansson et al., Randomised trial of effects of calcium antagonists compared with diureticsand beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study, LANCET, 356(9227), 2000, pp. 359-365
Authors:
Wachtell, K
Smith, G
Gerdts, E
Dahlof, B
Nieminen, MS
Papademetriou, V
Bella, JN
Ibsen, H
Rokkedal, J
Devereux, RB
Citation: K. Wachtell et al., Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study), AM J CARD, 85(4), 2000, pp. 466-472
Authors:
Dahlof, B
Citation: B. Dahlof, ACE inhibitors: the evidence in hypertension, INT J CL PR, 1999, pp. 11-13
Authors:
Waeber, B
Detry, JM
Dahlof, B
Puig, JG
Gundersen, T
Hosie, J
Januszewicz, W
Lindstrom, CJ
Magometschnigg, D
Safar, M
Tanser, P
Toutouzas, P
Citation: B. Waeber et al., Felodipine-metoprolol combination tablet: A valuable option to initiate antihypertensive therapy?, AM J HYPERT, 12(9), 1999, pp. 915-920
Authors:
Palmieri, V
Dahlof, B
DeQuattro, V
Sharpe, N
Bella, JN
de Simone, G
Paranicas, M
Fishman, D
Devereux, RB
Citation: V. Palmieri et al., Reliability of echocardiographic assessment of left ventricular structure and function - The PRESERVE study, J AM COL C, 34(5), 1999, pp. 1625-1632
Authors:
Willenheimer, R
Dahlof, B
Rydberg, E
Erhardt, L
Citation: R. Willenheimer et al., AT(1)-receptor blockers in hypertension and heart failure: clinical experience and future directions (vol 20, pg 1003, 1999), EUR HEART J, 20(24), 1999, pp. 1846-1846
Authors:
Willenheimer, R
Erhardt, L
Dahlof, B
Citation: R. Willenheimer et al., Simplified echocardiography: an accurate and inexpensive method for the assessment of left ventricular hypertrophy, EUR HEART J, 20(19), 1999, pp. 1437-1438
AT(1)-receptor blockers in hypertension and heart failure: clinical experience and future directions
Authors:
Willenheimer, R
Dahlof, B
Rydberg, E
Erhardt, L
Citation: R. Willenheimer et al., AT(1)-receptor blockers in hypertension and heart failure: clinical experience and future directions, EUR HEART J, 20(14), 1999, pp. 997-1008
Authors:
Hansson, L
Lindholm, LH
Ekbom, T
Dahlof, B
Lanke, J
Schersten, B
Wester, PO
Hedner, T
de Faire, U
Citation: L. Hansson et al., Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study, LANCET, 354(9192), 1999, pp. 1751-1756
Authors:
Hansson, L
Lindholm, LH
Niskanen, L
Lanke, J
Hedner, T
Niklason, A
Luomanmaki, K
Dahlof, B
de Faire, U
Morlin, C
Karlberg, BE
Wester, PO
Bjorck, JE
Citation: L. Hansson et al., Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial, LANCET, 353(9153), 1999, pp. 611-616
Authors:
Palmieri, V
Bella, JN
DeQuattro, V
Roman, MJ
Hahn, RT
Dahlof, B
Sharpe, N
Lau, CP
Chen, WC
Paran, E
de Simone, G
Devereux, RB
Citation: V. Palmieri et al., Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE study), AM J CARD, 84(5), 1999, pp. 558-562
Authors:
Dahlof, B
Citation: B. Dahlof, Definition of high blood pressure, epidemiology and goals of hypertension treatment, INT J CL PR, 1998, pp. 3-5
Authors:
Dahlof, B
Citation: B. Dahlof, Definition of high blood pressure, epidemiology and goals of hypertension treatment, DEAF EDUC, 1998, pp. 3-5
Authors:
Dahlof, B
Devereux, RB
Julius, S
Kjeldsen, SE
Beevers, G
de Faire, U
Fyhrquist, F
Hedner, T
Ibsen, H
Kristianson, K
Lederballe-Pedersen, O
Lindholm, LH
Nieminen, MS
Omvik, P
Oparil, S
Wedel, H
Citation: B. Dahlof et al., Characteristics of 9194 patients with left ventricular hypertrophy - The LIFE study, HYPERTENSIO, 32(6), 1998, pp. 989-997